Drotaverine acephyllinate

Drug Profile

Drotaverine acephyllinate

Alternative Names: Depogen

Latest Information Update: 14 Feb 1998

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Chinoin
  • Developer Chinoin; Nippon Zoki
  • Class Benzylisoquinolines; Peripheral vasodilators; Small molecules; Vascular disorder therapies
  • Mechanism of Action Cholinergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Peripheral vascular disorders

Most Recent Events

  • 14 Feb 1998 Discontinued-II for Peripheral vascular disorders in Japan (PO)
  • 14 Feb 1998 Discontinued-III for Peripheral vascular disorders in Hungary (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top